A detailed history of Daiwa Securities Group Inc. transactions in Insmed Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 635 shares of INSM stock, worth $45,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
635
Previous 585 8.55%
Holding current value
$45,250
Previous $39,000 17.95%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$62.0 - $79.01 $3,100 - $3,950
50 Added 8.55%
635 $46,000
Q2 2024

Aug 07, 2024

BUY
$22.0 - $69.71 $880 - $2,788
40 Added 7.34%
585 $39,000
Q4 2022

Feb 06, 2023

BUY
$16.98 - $23.15 $1,698 - $2,315
100 Added 22.47%
545 $11,000
Q2 2022

Aug 09, 2022

BUY
$17.07 - $25.71 $1,707 - $2,571
100 Added 28.99%
445 $9,000
Q4 2021

Feb 03, 2022

SELL
$25.89 - $33.45 $1,294 - $1,672
-50 Reduced 12.66%
345 $9,000
Q3 2021

Nov 05, 2021

BUY
$22.46 - $29.47 $4,289 - $5,628
191 Added 93.63%
395 $11,000
Q1 2021

May 03, 2021

BUY
$32.28 - $44.3 $387 - $531
12 Added 6.25%
204 $7,000
Q4 2020

Feb 04, 2021

SELL
$31.45 - $40.54 $12,076 - $15,567
-384 Reduced 66.67%
192 $6,000
Q3 2020

Nov 02, 2020

BUY
$26.0 - $34.5 $1,872 - $2,484
72 Added 14.29%
576 $19,000
Q4 2019

Jan 31, 2020

SELL
$16.12 - $24.98 $725 - $1,124
-45 Reduced 8.2%
504 $12,000
Q2 2019

Jul 24, 2019

BUY
$23.0 - $32.19 $1,288 - $1,802
56 Added 11.36%
549 $14,000
Q1 2019

Apr 26, 2019

BUY
$13.91 - $31.15 $973 - $2,180
70 Added 16.55%
493 $14,000
Q1 2018

May 02, 2018

BUY
$21.69 - $32.99 $9,174 - $13,954
423 New
423 $10,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.